The Lancet Group

eBioMedicine in conversation with

Health EN ↓ 29 episodes

Editors at eBioMedicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to this open access journal, this podcast covers a broad range of topics, from climate change and health to microplastics in human tissues, the microbiome-gut-brain axis and binge drinking to computational pathology in 2030, and more.

Author

The Lancet Group

Episodes

Jodi Sherman on the intersection between healthcare and climate change 27.10.2021 16:17

Jodi Sherman joins Julie Stacey and Liam Messin of eBioMedicine to discuss the intersection between healthcare and climate change. Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv

Grace Fox and Dr Manoj Lalu on the importance of patient engagement in preclinical research 22.09.2021 13:01

How can we ensure that research being conducted is relevant to its ultimate end-users? Grace Fox and Dr Manoj Lalu join eBioMedicine to discuss the importance of patient engagement in preclinical research. Further reading: Patient engagement in preclinical laboratory research: A scoping review Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instag...

Aleix Prat on chemotherapy and menopause 04.08.2021 9:43

Dr Aleix Prat on the relationship between chemotherapy effectiveness and menopause in patients with breast cancer. Further reading: https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(21)00244-9/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://link...

Viviana Simon and Maria Rescigno on mRNA vaccine dosing after prior infection 29.06.2021 14:14

Dr. Viviana Simon and Dr. Maria Rescigno discuss their proposal that people who have recovered from symptomatic COVID-19 may require only one dose of an mRNA vaccine. Further reading: https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(21)00194-8/fulltext Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https...